Strive, Inc. (ASST), the Nasdaq-listed asset-management and Bitcoin treasury company formerly known as Asset Entities, traded sharply lower on Monday. The stock fell roughly 6.90% to about $26.97 intraday, down from a prior-session close of $28.97, as a slide in Bitcoin below the $80,000 mark weighed on the shares. The move unwound part of last week's rally and reflected the market's renewed caution on risk assets heading into a pivotal stretch of economic data and central-bank news.
The dominant driver behind the sell-off was the pullback in Bitcoin itself. The leading cryptocurrency dropped below the $80,000 threshold during Monday's trading, pressured by profit-taking, a risk-off tone ahead of the Federal Reserve's policy meeting, and a stretch of outflows from U.S. spot Bitcoin exchange-traded funds. Because ASST derives its value primarily from its growing Bitcoin treasury, its shares act as a leveraged proxy for the digital asset's price, amplifying both gains and losses.
Monday's decline also followed a powerful rally. Shares jumped roughly 20% last week after Strive closed a $630 million initial public offering of its SATS perpetual preferred stock, capital earmarked to fund additional Bitcoin purchases. With the stock having run up sharply in a short period, traders moved to lock in gains once the underlying crypto market stalled, a pattern common in high-beta Bitcoin-treasury names.
Even positive corporate news failed to stem the decline. On Monday, Strive disclosed that it had acquired 6,182 additional Bitcoin for roughly $511 million between Oct. 17 and Oct. 23, lifting its total holdings to approximately 43,000 BTC at an average cost near $82,732 per coin. The company also unveiled a new at-the-market program allowing up to $1 billion in additional SATS sales over time. However, investors focused instead on the financing costs embedded in the strategy: the newly issued preferred stock carries a 15% annual dividend, and a wave of warrant exercises has expanded the common share count, diluting Bitcoin-per-share exposure for existing holders.
The decline in ASST unfolded against a backdrop of broader weakness in digital-asset markets, with Bitcoin briefly testing levels near $79,000 and major altcoins also trading lower. The stock has been among the most heavily shorted names in its category, adding to its characteristic volatility. While the broader equity indices showed modest resilience, crypto-correlated equities diverged to the downside, reflecting the sector-specific pressure rather than a broad-market sell-off. The move also pushed the shares back below short-term technical levels established during last week's breakout.
Investors will closely watch the Federal Reserve's rate decision and commentary, along with September PCE inflation data due later this week, both of which could drive Bitcoin and, by extension, ASST. The company's next quarterly earnings report and the start of its SATS dividend payments in November are additional near-term catalysts. Key risks include further deterioration in Bitcoin prices relative to the company's cost basis, the recurring cash obligations tied to its preferred equity, and the dilutive effects of continued capital raising. On the other hand, sustained accumulation and any recovery in Bitcoin above the $82,000–$85,000 range could quickly restore upward momentum in the shares.
Tickeron offers hundreds of AI-powered trading bots spanning thousands of tickers, but only the strongest performers under current market conditions are highlighted in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a range of approaches to explore. If you are looking for data-driven trading ideas across today's fast-moving markets, consider exploring the Trending AI Robots page to see which strategies are currently leading.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for ASST turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 24 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ASST's RSI Oscillator exited the oversold zone, 22 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ASST as a result. In 57 of 63 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
Following a +20.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 140 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
ASST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 61 of 78 cases where ASST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.378) is normal, around the industry mean (2.393). P/E Ratio (-39.088) is within average values for comparable stocks, (-3.286). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.272) among similar stocks. ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (15.798).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers